版本:
中国

BRIEF-ProQR reports Q1 loss per share EUR 0.45

May 17 Proqr Therapeutics Nv

* ProQR announces results for the first quarter of 2017

* Q1 loss per share EUR 0.45

* ProQR Therapeutics NV - at March 31, 2017, ProQR held cash and cash equivalents of EUR 52.1 million, compared to EUR 59.2 million at December 31, 2016

* ProQR Therapeutics NV - top-line results from trial PQ-110-001 are expected to be available in 2018 Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐